Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patients.
Bevacizumab treatment can result in tumor shrinkage of progressive vestibular schwannomas in some neurofibromatosis 2 (NF2) patients but its effect on meningiomas has not been defined. To determine the clinical activity of bevacizumab against NF2-related meningiomas, we measured changes in volume of...
Enregistré dans:
Auteurs principaux: | Fabio P Nunes, Vanessa L Merker, Dominique Jennings, Paul A Caruso, Emmanuelle di Tomaso, Alona Muzikansky, Fred G Barker, Anat Stemmer-Rachamimov, Scott R Plotkin |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f1f7da0af9c04824ac2ec64c9d11a7a4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Genomic landscape of high-grade meningiomas
par: Wenya Linda Bi, et autres
Publié: (2017) -
Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.
par: Long-Sheng Chang, et autres
Publié: (2021) -
Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas
par: Sameer Agnihotri, et autres
Publié: (2017) -
Isolated Intraconal Meningioma
par: Mohammad Taher Rajabi, et autres
Publié: (2021) -
Intraosseous meningioma mimicking osteosarcoma
par: Ruben Delgado, et autres
Publié: (2021)